Oral Oncology
Volume 39, Issue 7 , Pages 687-694 , October 2003

Maxillofacial manifestations of Langerhans cell histiocytosis: a clinical and therapeutic analysis of 10 patients

Received 20 January 2003 ,Accepted 3 April 2003.

References 

  1. Nezelof C, Basset F, Rousseau MF. Histiogenetic arguments for a Langerhans cell origin. Biomedicine. 1973;18:365–371
  2. Writing Group of the Histiocyte Society . Histiocytosis syndromes in the childhood. Lancet. 1987;1:208–209
  3. Kelly KM, Pritchard J. Monoclonal antibody therapy in langerhans cell histiocytosis—feasible and reasonable?. Br J Cancer. 1994;70(23):54–55
  4. Brenner M. Currnt status of gene transfer into hamatopoietic progenitor cells: application to langerhans cell histiocytosis. Br J Cancer. 1994;70(23):56–57
  5. Oelench M, Vestring T. Unklare Osteolyse des rechten Unterkiefers. Radiologe. 1993;33:597–599
  6. Steurer J, Furrer J, Rhyner K, Vetter W, Siegenthaler W. Histiocytosis X—Klinik und Verlauf bei fünf Patienten. Dtsch Med Wochenschr. 1991;116:1702–1709
  7. Schajowicz F. Eosinophilic granuloma. In:  Schajowicz X editors. Tumors and tumor-like lesions of bone: pathology, radiology and treatment. Berlin Heidelberg\New York: Springer; 1994;p. 552–566
  8. Stoll M, Freund M, Schmidt H, Deicher H, Riehm H, Poliwoda H, et al. Allogeneic bone marrow transplantation for Langerhans’ cell histiocytosis. Cancer. 1990;66:284–288
  9. Bhatia S. Nesbit ME, Egeler M, Buckley JD, Mertens A, Robison LL Epidemiologic study of Langerhans cell histiocytosis in children. J Pediatr. 1997;130:774–784
  10. Betts DR, Leibundgut KE, Feldges A, Plüss HJ, Niggli FK. Cytogenetic abnormalities in Langerhans cell histiocytosis. Br J Cancer. 1998;77:552–555
  11. Wu WS, McClain KL. DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promotor in Langerhans cell histiocytosis (LCH). J Interferon Cytokine Res. 1997;17:631–635
  12. Pinkus GS, Lones MA, Matsumura F, Yamashiro S, Said JW, Pinkus JL. Langerhans cell histiocytosis immunohistochemical expression of fascin, a dendritic caD marker. Am J Clin Pathol. 2002;18:335–343
  13. Burgener FA. Die Röntgenmanifestation der disseminierten Histiocytosis X beim Erwachsenen. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 1977;126:466
  14. David R, Oria RA, Kumar R, Singleton EB, Lindell MM, Shirkhoda A, et al. Radiologic features of eosinophilic granuloma of bone. MR Am J Roentgenol. 1989;153:1021
  15. Favara BE, Jaffe R. Pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1987;1:75
  16. Liebermann PH, Steinmann RM, Smith J, Garin-Chesa P, Urmacher C, Sperber M. Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years. Am. J. Surg. Pathol. 1996;20:519–552
  17. Chu T, Jaffe R. The normal Langerhans cell and the LCH cell. Br J Cancer. 1994;23:4–9
  18. Crone-Munzenbrock W, Brassow F. A comparison of radiographic and bone scan findings in histiocytosis X. Skelet Radiol. 1983;9:170
  19. Malpas JS, Norton AJ. Langerhans cell histiocytosis in the adult. Med Pediatr Oncol. 1996;27:540–546
  20. Favara BE. FellerAC Contemporary classification of histiocytic disorders. Med Pediatr Oncol. 1997;29:157–166
  21. Leikin SL. lmmunobiology of histiocytosis X. Hematol Oncol Clin North Am. 1987;1:49–61
  22. Giona F, Caruso R, Testi AM, Moleti ML, Malagnino F, Martelli M, et al. Langerhans’ cell histiocytosis in adults. A clinical and therapeutic analysis of 11 patients from a single institution. Cancer. 1997;80:1786–1791
  23. Riviera-Luna R, Alter-Molchadsky N, Cardenas-Cardos R, Martinez-Guerra G. Langerhans cell histiocytosis in children under 2 years of age. Med Pediatr Oncol. 1996;26:334–343
  24. Lavin TP, Osband ME. Evaluating the role of therapy in histiocytosis-X (clinical studies, staging and scoring). Hematol Oncol Clin North Am. 1987;1:35–47
  25. Libicher M. Roeren 1, Tröger Localized Langerhans’ cell histiocytosis of bone (treatment and follow-up in children). Pediatr Radiol. 1995;25:134–137
  26. McCowage GB, Frush DP, Kurtzberg J. Successful treatment of two children with Langerhans’ cell histiocytosis with 2′-deoxycoformycin. J Pediatr Hematol Oncol. 1996;18:154–158
  27. Basade MM, Nair CN, Kurkure PA, Pai SK, Advani SH. Etoposide in Langerhans cell histiocytosis in children (a preliminary experience). Med Pediatr Oncol. 1996;13:159–162
  28. Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S. Treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatr Oncol. 1994;23:72–80
  29. Ladisch S, Gadner H, Aric M, Broadbent V, Grois N. Jacobson A Komp D, Nicholson HS LCH-I (a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis). Med Pediatr Oncol. 1994;23:107–110
  30. Starling KA. Chemotherapy of histiocytosis. Am J Pediatr Hernatol Oncol. 1981;3:157–160
  31. Jones B, Kung F, Chevalier L. Chemotherapy of reticuloendotheliosis. Comparison of methotrexate plus prednisolone vs. vincristine plus prednisolone. Cancer. 1974;34:1011–1017
  32. Hirose M, Saito S, Yoshimoto T, Kuroda Y. Interleukin-2 therapy of Langerhans cell histiocytosis. Acta Paediatr. 1995;84:1204–1206
  33. Brenez D, Devriendt J, Lenclud C, Schmerber J. Acute nonlymphocytic leukemia following chemotherapy with cisplatin and etoposide for non-small-cell carcinoma of the lung. Cancer Chemother Pharmacol. 1990;26:235–236
  34. Haupt R, Comelli A, Rosanda C, Sessarego M, De Bernardi B. Acute myeloid leukemia after single-agent treatment with etoposide for Langerhans cell histiocytosis of bone. Am J Pediatr Hematol Oncol. 1993;15:255–257
  35. Hawkins MM, Wilson LMK, Stovall MA, Mardsen HB, Potok MH, Kingston JE, et al. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukemia after childhood cancer. BMJ. 1992;304:951–958
  36. Komp DM, Vietti TJ, Berry DH. Combination therapy in histiocytosis x. Med Pediatr Oncol. 1977;3:267–273
  37. Lahey ME. Histiocytosis X—comparison of three treatment regimens. J Pediatr. 1975;87:179–183
  38. Pedersen-Bjergaard J, Daugaard G, Hansen SW, Philip P, Larson SO, Rorth M. Increased risk of myelodysplasia and leukemia after etoposide, cisplatin and bleomycin for germ-cell tumors. Lancet. 1991;338:359–363
  39. The Clinical Writing Group of the Histiocyte Society . Histiocytosis syndromes in the childhood (II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis). Med Pediatr Oncol. 1989;17:492–495
  40. Hartman KS. Histiocytosis X (a review of 114 cases with oral involvement). Oral Surg Oral Med Oral Pathol. 1980;49:38–54
  41. Chomette G, Auriol M, Ragot JP, Guilbert F. Histiocytosis X of the jaw. I. Anatomico-clinical study apropos of 61 cases. Rev Stomatol Chir Maxillofac. 1987;88:334–338
  42. Bartnick A, Friedrich RE, Roeser K, Schmelzle R. Oral Langerhans cell histiocytosis. J Cranio Maxillofac Surg. 2002;30:91–96

PII: S1368-8375(03)00080-0

doi: 10.1016/S1368-8375(03)00080-0

Oral Oncology
Volume 39, Issue 7 , Pages 687-694 , October 2003

Article Tools

* Image Usage & Resolution